CAR‑HEMATOTOX Score Shows Prognostic Utility for CAR‑T Therapy in Relapsed/Refractory Multiple Myeloma
Researchers sought to determine whether the CAR‑HEMATOTOX score would have prognostic value for both toxicity and treatment response in patients with R/R MM receiving CAR-T therapy.